Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Decoy Therapeutics Inc. (DCOY)

Decoy Therapeutics sets July 14, 2026 date for 2026 annual stockholder meeting

Neutral Impact 2 of 5 shareholder Written later

Decoy Therapeutics set July 14, 2026 as the date of its 2026 Annual Meeting of Stockholders, and disclosed new deadlines for stockholder proposals and director nominations. The filing is procedural: it tells shareholders when they must act to present proposals or nominees, and that meeting details will come in a later proxy statement.

Key points

  • Board set July 14, 2026 as the 2026 Annual Meeting date, on May 12, 2026
  • Stockholders of record at close of business on May 22, 2026 are entitled to vote
  • Deadline for Rule 14a-8 proposals for the proxy statement is close of business on May 29, 2026
  • Advance notice deadline for other proposals and director nominations is May 29, 2026

The filing

CompanyDecoy Therapeutics Inc. (DCOY)
Form8-K, current report
Filed with the SECMay 19, 2026, 4:06 PM ET
Accession number0001193125-26-230749

Items reported: 5.08 Shareholder Director Nominations8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 19, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.